Publications by authors named "Shoya Ino"

Claim this Profile
I
Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan.
Shingo Kuwajima, Takahito Itoh, Tatsuya Sato, Shoya Ino, Satoru Shibata

Diabetol Int· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts.
Shoya Ino, Toshiyuki Yano, Atsushi Kuno, Masaya Tanno, Hidemichi Kouzu

J Pharmacol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts.
Toshifumi Ogawa, Hidemichi Kouzu, Arata Osanami, Yuki Tatekoshi, Tatsuya Sato, Shoya Ino

Physiol Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sacubitril/Valsartan on Glycemic Control in Japanese Patients With Heart Failure and/or Hypertension.
Kahomi Sazawa, Kohei Ohno, Tomohisa Yamashita, Shoya Ino, Satoru Shibata

Circ Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation.
Koki Abe, Toshiyuki Yano, Masaya Tanno, Takayuki Miki, Atsushi Kuno, Shoya Ino

Biochim Biophys Acta Mol Basis Dis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis